About Dayton Reardan
Dayton Reardan is a chairman, co-founder at Niche Biopharmaceuticals.
Dayton Reardan first appears on SEC filings in 2021.
Experience
This experience comes from Dayton Reardan's profile and from SEC filings. For roles taken from filings, the years are when the filings name Dayton Reardan in the role, so the role may have started earlier or lasted longer.
Niche Biopharmaceuticals LLC Current
Chairman, Co-founder
Chairman and Founder (2020 – Present)
2020 – Present · Shorewood, MN
Develops a topical treatment for people with eczema and diabetic foot ulcers.
TP
TPIreg Current
Director, US Regulatory Affairs
2015 – Present
EP
Effexus Pharmaceuticals
Vice President, Regulatory Affairs
2015 – 2016
SP
SpineThera
Vice President, Regulatory Affairs
2015 – 2016
QL
QOL Medical LLC
Vice President, Regulatory Affairs
2011 – 2015
AT
Altheus Therapeutics
Chief Operating Officer
2009 – 2014
EI
Eleos Inc.
Vice President of Regulatory Affairs
2006 – 2011
OM
orphan medical
Vice President of Regulatory Affairs
1994 – 2004
Key Colleagues at Startups
The people Dayton Reardan works with at each company, as listed on that company's latest Form D.
Niche Biopharmaceuticals LLC · Form D, May 11, 2026
DS
Daniel Saccani
Chief Financial Officer and director
PS
Patrick Schlievert
CSO, Co-founder and director
RK
Robert Klem
Director
PB
Paul Brennan
Board Member